Cellebrite (NASDAQ: CLBT) director details 40,795 shares and 10,601 RSUs in Form 3

Rhea-AI Filing Summary

Cellebrite DI Ltd. director Utsumi Ryusuke filed an initial statement of beneficial ownership. He reports direct holdings of 40,795 Ordinary Shares and 10,601 Restricted Stock Units, each representing a right to receive one Ordinary Share. The restricted stock units vest on September 17, 2026, reflecting future potential equity ownership rather than a current share issuance.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Utsumi Ryusuke

Role Director

Type	Security	Shares	Price	Value
holding	Restricted Stock Units	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Restricted Stock Units — 10,601 shares (Direct); Ordinary Shares — 40,795 shares (Direct)

Footnotes (1)

1. The restricted stock units vest on September 17, 2026. Each restricted stock unit represents a contingent right to receive one ordinary share.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Utsumi Ryusuke

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

3a. Foreign Trading Symbol
[9W9]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	40,795	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Ordinary Shares	10,601(2)	(2)	D

Explanation of Responses:

1. The restricted stock units vest on September 17, 2026.

2. Each restricted stock unit represents a contingent right to receive one ordinary share.

	/s/ Ryusuke Utsumi	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)